LineaBio’s mission is to enable the cell and gene therapy industry by providing access to high-quality, off-the-shelf iPSC lines manufactured under GMP that streamline drug product manufacturing. By allowing therapeutic developers to cut costs and accelerate timelines for GMP reprogramming, LineaBio strives to achieve its vision of making cell therapy universally accessible and affordable. Founded in 2023 by parent companies CCRM and OmniaBio, LineaBio draws on a team of iPSC experts that have been developing an iPSC platform for more than a decade.
Company Details
- Founded
- -
- Address
- 661 University Avenue, Suite 1002,canada
- Industry
- Manufacturing
- NAICS
-
ManufacturingBeverage and Tobacco Product ManufacturingMiscellaneous ManufacturingTextile Furnishings MillsOther Textile Product MillsOther Miscellaneous ManufacturingCarpet and Rug MillsCurtain and Linen MillsTextile Bag and Canvas MillsAll Other Textile Product MillsJewelry and Silverware ManufacturingDoll, Toy, and Game ManufacturingOffice Supplies (except Paper) ManufacturingSign ManufacturingAll Other Miscellaneous ManufacturingRope, Cordage, Twine, Tire Cord, and Tire Fabric MillsAll Other Miscellaneous Textile Product MillsGasket, Packing, and Sealing Device ManufacturingMusical Instrument ManufacturingFastener, Button, Needle, and Pin ManufacturingBroom, Brush, and Mop ManufacturingBurial Casket Manufacturing
- Website
- http://www.lineabio.com
- Keywords
- in the field of iPSCs..
- HQ
- Toronto, Ontario
Lineabio Questions
Lineabio's website is http://www.lineabio.com
Lineabio's LinkedIn profile is https://ca.linkedin.com/company/lineabio
Lineabio's industry is
Manufacturing
Lineabio's top competitors are
Omniabio,
Virica Biotech,
Avrobio,
Providence Therapeutics,
Notch Therapeutics,
Biocanrx,
Thermo Fisher Scientific,
Ccrm,
Dark Horse Consulting Group Inc.,
Bluerock Therapeutics.
Lineabio's categories are Manufacturing
Lineabio's founding year is 2023
